Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fayette

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|May 13, 2009
[Chemoprevention in head and neck cancer and lung cancer]J Fayette, L Kiakouama
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 6, 2005
[Chemotherapy of sarcomas: optimization of existing drugs and new molecules]J Fayette, J-Y Blay
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 6, 2005
[Soft tissues sarcomas: good medical practices for an optimal management]J Fayette, J Y Blay, I Ray-Coquard
Pathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P Armand
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytesB Dubois, C Massacrier, B Vanbervliet, et al.
The Journal of Experimental Medicine|March 3, 1997
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytesB Dubois, B Vanbervliet, J Fayette, et al.
The Journal of Experimental Medicine|June 2, 1997
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2J Fayette, B Dubois, S Vandenabeele, et al.
Scandinavian Journal of Immunology|January 5, 1999
Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitroJ Fayette, I Durand, J M Bridon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2007
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 casesJ Fayette, E Martin, S Piperno-Neumann, et al.
Bulletin Du Cancer|September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet, J Bourhis, L Cals, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|May 13, 2009
[Chemoprevention in head and neck cancer and lung cancer]J Fayette, L Kiakouama
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 6, 2005
[Chemotherapy of sarcomas: optimization of existing drugs and new molecules]J Fayette, J-Y Blay
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 6, 2005
[Soft tissues sarcomas: good medical practices for an optimal management]J Fayette, J Y Blay, I Ray-Coquard
Pathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P Armand
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytesB Dubois, C Massacrier, B Vanbervliet, et al.
The Journal of Experimental Medicine|March 3, 1997
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytesB Dubois, B Vanbervliet, J Fayette, et al.
The Journal of Experimental Medicine|June 2, 1997
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2J Fayette, B Dubois, S Vandenabeele, et al.
Scandinavian Journal of Immunology|January 5, 1999
Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitroJ Fayette, I Durand, J M Bridon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2007
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 casesJ Fayette, E Martin, S Piperno-Neumann, et al.
Bulletin Du Cancer|September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet, J Bourhis, L Cals, et al.
Pageof 3